Home / Generics

Generics

News

New generic versions of imatinib mesylate join the US market posted 26/08/2016

Two new generic versions of Novartis’ imatinib mesylate (marketed as Gleevec® and Glivec®) were launched in the US in early A...

Launches, approvals and court cases for Sun Pharma posted 21/08/2016

India’s largest drug manufacturer Sun Pharmaceutical Industries (Sun Pharma) has launched ready-to-administer anticancer drug...

FDA approves first generic nilutamide for treatment of prostate cancer posted 12/08/2016

US generics producer ANI Pharmaceuticals (ANI) announced on 18 July 2016 that it had received US Food and Drug Administration...

Glenmark gains approval for anti-epileptic generic posted 24/06/2016

Indian generics maker Glenmark Pharmaceuticals (Glenmark) announced on 19 May 2016 that it had received final approval from t...

Dr Reddy’s to buy US generics from Teva posted 17/06/2016

Generics giant Dr Reddy’s Laboratories (Dr Reddy’s) announced on 11 June 2016 that it had made a deal with Teva Pharmaceutica...

 

Research

Generics in seizure control posted 26/08/2016

Are generic medicines for the control of epileptic seizures bioequivalent to their brand-name counterparts? Steven Karceski [...

The satisfaction of healthcare payers, patients and physicians with generic imatinib posted 05/08/2016

With the begining of the era of tyrosine kinase inhibitors (TKIs), chronic myeloid leukaemia (CML) became a chronic disease,...

Ways to reduce drug costs in Australia posted 29/07/2016

Drug costs in Australia are increasing at an alarming rate. This is driven mainly by expensive biological therapies, antivira...

AES position statement on substitution of generic anti-epileptics posted 04/07/2016

A paper by the American Epilepsy Society (AES) discusses how the society’s position on generics substitution of anti-epilepti...

Reasons for the success of a generics company in the Sudan market posted 24/06/2016

An exploratory, qualitative study carried out by colleagues from the University of Khartoum (Sudan) and Abertay University (U...

 

General

EMA halts sales of unreliable generics posted 21/08/2016

The European Medicines Agency (EMA) has recommended that the sales of several generics, including those produced by Teva and...

Extortionate increases in prices of 32 drugs a result of loophole in NHS pricing structure posted 08/08/2016

An investigation by The Times has exposed a small group of UK-based entrepreneurs to have profited vast amounts of money from...

Healthcare alliance proposes ways to reduce drug costs in the US posted 01/07/2016

Recent price increases in the US have prompted an alliance of doctors, pharmacists and health plan groups to release a docume...

China cuts prices for three drugs by more than 50% posted 23/06/2016

In an effort to lower spending on prescription drugs, China has cut the prices for three patent-protected drugs by more than...

Australian generics maker opens clinical trials facility posted 20/05/2016

IDT Australia announced on 2 May 2016 that it had opened a new clinical trials facility in Adelaide.

Generics News Research General

more

Biosimilars News Research General

more